Melanoma Clinical Trials in Lund
5 recruitingLund, Sweden
Showing 1–5 of 5 trials
Recruiting
Phase 3
Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
High-risk Melanoma
Uppsala University1,792 enrolled26 locationsNCT06488482
Recruiting
Phase 3
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Advanced Melanoma
Immunocore Ltd680 enrolled211 locationsNCT06112314
Recruiting
Phase 1Phase 2
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Ovarian CancerMelanomaT-cell Lymphoma+1 more
BioInvent International AB176 enrolled25 locationsNCT04752826
Recruiting
Phase 3
SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
Malignant Melanoma Stage III
Hildur Helgadottir128 enrolled3 locationsNCT06794775
Recruiting
Phase 3
PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
Liver MetastasesUveal Melanoma
Vastra Gotaland Region40 enrolled6 locationsNCT06519266